Photo: Warren Zelman
Medicines are a critical component of quality health care. In fact, most of the leading causes of death and disability in low- and middle-income countries could be prevented or treated with the appropriate use of affordable, effective medicines.
Yet, about two billion people -- one third of the world’s population -- lack consistent access to essential medicines. Fake and substandard medicines exacerbate the problem. When these people fall ill and seek treatment, too often they end up with small quantities, high prices, poor quality, and the wrong drug. This leads to prolonged suffering, and even death.
Management Sciences for Health (MSH) is a global leader on pharmaceutical management and universal health coverage (UHC). MSH’s expertise in strengthening pharmaceutical management in low- and middle-income countries is built around a systems approach that emphasizes sustainability and strengthened local capacity -- ensuring lasting changes in the systems that support greater access to and use of quality medicines and related pharmaceutical services. This country-led, country-owned, systems approach is paying off in countries across the globe where major strides are being taken toward UHC.